申请人:Gilead Sciences, Inc.
公开号:US08809527B2
公开(公告)日:2014-08-19
Provided are modulators of TLRs of Formula II:
pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
提供了公式II的TLR调节剂:其药学上可接受的盐,含有这些化合物的组合物以及包括这些化合物的给药的治疗方法。